MARAMAI SAMUELE | Professor page

Ciccone, V., Cecchin, C., Frosini, M., Saletti, M., Maramai, S., Giuliani, G., et al. (2026). VA1213, a selective COX-2 inhibitor, exhibits antitumor activity by suppressing EGFR, AKT, and ERK1/2 phosphorylation. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES [10.1016/j.ejps.2025.107422]. - view more
Cazzola, J., Talpo, F., Faravelli, G., Donati, C., Maramai, S., Saletti, M., et al. (2025). Evaluation of a New Riluzole‐Based Compound VA945 on Sodium and Potassium Conductances Expressed by SH-SY5Y-Derived Neurons. JOURNAL OF NEUROCHEMISTRY, 169(11) [10.1111/jnc.70280]. - view more
Maramai, S., Taddei, M., Castagnetti, A., Viciani, E., Koufi, F., Neri, I., et al. (2025). Drug enteric metabolism in gut microbiota-brain crosstalk. LIFE SCIENCES, 383 [10.1016/j.lfs.2025.124075]. - view more
Maramai, S., Mugnaini, C., Paolino, M., Schiano Moriello, A., De Petrocellis, L., Corelli, F., et al. (2025). Indole-2-Carboxamide as an Effective Scaffold for the Design of New TRPV1 Agonists. MOLECULES, 30(3) [10.3390/molecules30030721]. - view more
Paolino, M., Saletti, M., Venditti, J., Castriconi, F., Giuliani, G., Maramai, S., et al. (2025). Use of imidazo[1,5-a]quinoline scaffold as the pharmacophore in the design of bivalent ligands of central benzodiazepine receptors. BIOORGANIC & MEDICINAL CHEMISTRY, 117 [10.1016/j.bmc.2024.118006]. - view more